“ALLHAT”-Type Cardio Safety Trial For COX-2s, NSAIDs Urged By FDA

FDA would like to see an "ALLHAT"-like study conducted with COX-2 inhibitors and non-selective NSAIDs to determine the relative gastrointestinal and cardiovascular safety of the two drug classes